In a devastating blow to Novartis, a federal judge denied a bid to overturn a verdict in which a jury decided the drugmaker failed to adequately warn about the risks that its Zometa and Aredia bone-strengthening meds caused severe jaw bone damage. And in making his decision, he writes that the jury was shown sufficient evidence to conclude a cover-up was undertaken with “the knowledge and approval of high-ranking officials.”
Read article at pharmalot.com
Friday, November 25, 2011
Novartis: Criminal Cover-Ups and Jawbone Damage from Zometa and Aredia
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";